List of SBIR/STTR awards granted to AGENNIX, INC.

List of SBIR/STTR awards granted to AGENNIX, INC.

List of SBIR/STTR awards granted to WW TECHNOLOGY GROUP, INC

List of SBIR/STTR awards granted to Green Mountain Radio Research Company

List of SBIR/STTR awards granted to Soymeds Inc

Battery management system venture capital investors

List of funding rounds for Deloitte Touche Tohmatsu Services, LLC

where

SBIR/STTR Award Recipient

is

AGENNIX, INC.

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ AGENNIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AGENNIX, INC. for $349,929.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR	1R43DE015914-01	Phase I	349,929		sbir.gov/content/recombinant-human-lactoferrin-treat-oral-mucositis-0
	‌ AGENNIX, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to AGENNIX, INC. for $715,265.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR	4R44AR049961-02	Phase II	715,265		sbir.gov/content/safety-and-efficacy-rh-lactoferrin-diabetic-ulcers-2
	‌ AGENNIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AGENNIX, INC. for $115,800.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR	1R41HD046305-01A1	Phase I	115,800		sbir.gov/node/1067211
	‌ AGENNIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AGENNIX, INC. for $570,399.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR	1R44GM077816-01A2	Phase I	570,399		sbir.gov/content/treatment-sepsis-talactoferrin-0
	‌ AGENNIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AGENNIX, INC. for $130,595.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR	1R43GM076741-01	Phase I	130,595		sbir.gov/content/treatment-sepsis-using-recombinant-human-lactoferrin-0
	‌ AGENNIX, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to AGENNIX, INC. for $749,920.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR	2R44AI058553-02	Phase II	749,920		sbir.gov/content/phase-ii-clinical-trial-lactoferrin-asthma-0
	‌ AGENNIX, INC. STTR Phase I Award,	A STTR Phase I contract was awarded to AGENNIX, INC. for $115,800.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			STTR	1R41HD046305-01A1	Phase I	115,800		sbir.gov/content/recombinant-lactoferrin-and-necrotizing-enterocolitis-0
	‌ AGENNIX, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to AGENNIX, INC. for $571,731.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR	4R44HD057744-02	Phase II	571,731		sbir.gov/content/lactoferrin-enhances-growth-and-reduces-nosocomial-infection-preterm-infants-2
	‌ AGENNIX, INC. STTR Phase II Award,	A STTR Phase II contract was awarded to AGENNIX, INC. for $274,703.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			STTR	PHS2001-2	Phase II	274,703		sbir.gov/content/therapy-gastrointestinal-disorders-4
	‌ AGENNIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AGENNIX, INC. for $557,320.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR	1R44HD057744-01A1	Phase I	557,320		sbir.gov/content/lactoferrin-enhances-growth-and-reduces-nosocomial-infection-preterm-infants-0
	‌ AGENNIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AGENNIX, INC. for $100,035.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR	1R44AR049961-01	Phase I	100,035		sbir.gov/content/safety-and-efficacy-rh-lactoferrin-diabetic-ulcers-0
	‌ AGENNIX, INC. STTR Phase I Award,	A STTR Phase I contract was awarded to AGENNIX, INC. from the U.S. Department of Health & Human Services.	AGENNIX, INC.			STTR	PHS2001-2	Phase I	0		sbir.gov/content/therapy-gastrointestinal-disorders-2
	‌ AGENNIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AGENNIX, INC. for $99,925.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR	1R43AI058553-01	Phase I	99,925		sbir.gov/content/lactoferrin-primate-and-mouse-models-asthma-0
	‌ AGENNIX, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to AGENNIX, INC. for $2,462,040.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR	4R44GM077816-02	Phase II	2,462,040		sbir.gov/content/treatment-sepsis-talactoferrin-2
	‌ AGENNIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AGENNIX, INC. for $100,733.0 USD from the U.S. Department of Health & Human Services.	AGENNIX, INC.			SBIR		Phase I	100,733		sbir.gov/content/not-available-720

15 results

0 selected

15 results

0 selected